ask="1.0000"
ask_size="2000"
average_daily_volume="N/A"
bid="0.0100"
bid_size="5000"
book_value="0.0000"
change="-0.0389"
change_from_200_day_moving_average="0.2104"
change_from_50_day_moving_average="0.2104"
change_from_52_week_high="0.0000"
change_From_52_week_low="0.0000"
change_in_percent="-15.6037%"
close="0.2104"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="N/A"
high="0.2104"
high_52_weeks="0.2104"
last_trade_date="2/2/2017"
last_trade_price="0.2104"
last_trade_size="200"
last_trade_time="4:00pm"
low="0.2104"
low_52_weeks="0.2104"
market_capitalization="N/A"
moving_average_200_day="0.0000"
moving_average_50_day="0.0000"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="N/A"
open="0.2104"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+inf%"
percent_change_from_50_day_moving_average="+inf%"
percent_change_from_52_week_high="+0.0000%"
percent_change_from_52_week_low="+0.0000%"
previous_close="0.2493"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.0000"
stock_exchange="NCM"
symbol="EYEGW"
volume="200"
weeks_range_52="0.2104 - 0.2104"
